Global Rib Fracture Treatment Market, By Treatment Type (Therapy, Drugs, Others), Route of Administration (Oral, Parenteral, Others), End Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) - Industry Trends and Forecast to 2029.
Market Analysis and Insights
When enough force is applied on the rib, it is bound to fracture. Most isolated rib fractures can be managed hopefully. Nevertheless, specific patterns of rib fractures are related to the higher illness and mortality and will need further evaluation for other underlying injuries and developing treatment.
The rib fracture treatment is supportive and aims to reduce the severity of the symptoms. Data Bridge Market Research analyses that the rib fracture treatment market was valued at USD 400 million in 2021 and is likely to reach USD 604.63 million by 2029, and will grow at a CAGR of 5.30% during the forecast period of 2022 to 2029.
Report Scope and Market Segmentation
2022 to 2029
2020 (Customizable to 2019 - 2014)
Revenue in USD Million, Volumes in Units, Pricing in USD
Treatment Type (Therapy, Drugs, Others), Route of Administration (Oral, Parenteral, Others), End Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Market Players Covered
Novartis AG (Switzerland), Sun Pharmaceutical Industries Ltd. (India), Larken Laboratories (US), Teva Pharmaceutical Industries Ltd. (Israel), Cipher Pharmaceuticals Inc. (Canada), Mylan N.V. (US), Purdue Pharma L.P. (US), Allergan plc (US), USWM, LLC. (US), GlaxoSmithKline plc. (UK), and Pfizer Inc. (US).
Rib Fracture Treatment Market Dynamics
- The rise in the cases of low bone density.
The human vulnerability to rib fractures and injuries presents and unbalanced food diet a favourable case for global market expansion.
- The growing accidental cases, hard falls, domestic issues and other type of violence
Growing amount of excessive playing of contact sports including football and rugby is further anticipated to propel the growth of the rib fracture treatment market.
- The increase in the geriatric population.
Growing of the aging population due to the natural phenomenon of aging leading to have fragile bone structure which is further contributing to the market growth.
In addition, the growing cases of rib facture, rising cases of osteoporosis and arthritis and rise in the healthcare infrastructure will further provide potential opportunities for the growth of rib fracture treatment market in the coming years.
On the flip side, the stringent regulatory guidelines for the approval new treatment is further projected to impede the growth of the rib fracture treatment market in the timeline period. However, the increased expenses of surgeries and therapy and unsuitable reimbursement policies which might further challenge the growth of the rib fracture treatment market in the near future.
This rib fracture treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on rib fracture treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
These fractures are rarely life-threatening in themselves but can be an external marker of more severe visceral injury inside the abdomen and the chest. Approximately 10% of all patients admitted after blunt chest trauma have one or more rib fractures.
The rib fracture market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Covid-19 Impact on Rib Fracture Treatment Market
Advancements in healthcare manufacturing have emerged as a resilient dynamic of market growth over the recent past. The ongoing COVID-19 pandemic has also helped in sensitizing people towards the use various healthcare technologies. Lockdowns and isolation during pandemics have complicate the healthcare management and medication adherence. The lack of access to health-care facilities for routine treatment and medication administration will further affect the market. Social isolation increases stress, despair, and social support, all of which may cause a reduction in treatment adherence during the pandemic.
- In 2021, Johnson & Johnson’s subsidiary company DePuy Synthes announced launch of 2.7mm variable angle locking compression plate. This plate is used in lateral, shaft and medical fractures of clavicles.
- In 2019, Johnson & Johnson’s subsidiary company DePuy Synthes announced launch of femoral neck system. This is an innovative implant for treatment of femoral neck fractures.
- In 2019, Smith & Nephew announced launch of CONQUEST FN. This product is used in femoral neck fracture treatment.
Global Rib Fracture Treatment Market Scope
The rib fracture treatment market is segmented on the basis of treatment type, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
On the basis of treatment type, the rib fracture treatment market is segmented into therapy, drugs and others. Drugs further sub segmented into anti-inflammatory, analgesic and others.
Route of Administration
On the basis of route of administration, the rib fracture treatment market is segmented into oral, parenteral, and others.
- Specialty Clinics
On the basis of end users, the rib fracture treatment market is segmented into hospitals, specialty clinics and others.
- Hospital Pharmacy
- Retail Pharmacy
On the basis of distribution channel, the rib fracture treatment market has also been segmented into hospital pharmacy, retail pharmacy and others.
Rib Fracture Treatment Market Regional Analysis/Insights
The rib fracture treatment market is analysed and market size insights and trends are provided by country, treatment type, route of administration, end-users and distribution channel as referenced above.
The countries covered in the rib fracture treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the rib fracture treatment market due to the high demand of rib fracture treatment for treating trauma cases and sports related injuries. Furthermore, growing healthcare infrastructure will further boost the growth of the rib fracture treatment market in the region during the forecast period.
Asia-Pacific is projected to observe significant amount of growth in the rib fracture treatment market due to the constant rise in the population. Moreover, the growing incidence of rib facture cases is further anticipated to propel the growth of the rib fracture treatment market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Rib Fracture Treatment Market Share Analysis
The rib fracture market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to rib fracture market.
Some of the major players operating in the rib fracture treatment market are:
- Novartis AG (Switzerland)
- Sun Pharmaceutical Industries Ltd. (India)
- Larken Laboratories (US)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Cipher Pharmaceuticals Inc. (Canada)
- Mylan N.V. (US)
- Purdue Pharma L.P. (US)
- Allergan plc (US)
- USWM, LLC. (US)
- GlaxoSmithKline plc. (UK)
- Pfizer Inc. (US)
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.